Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (279)
- COVID-19 (163)
- Safety monitoring and information (104)
- Legislation (96)
- Compliance and enforcement (72)
- Manufacturing (57)
- Vaping hub (55)
- Labelling and packaging (38)
- Import and export (29)
- Scheduling (national classification system) (27)
- Medicinal cannabis hub (25)
- Sunscreens (18)
- Weight loss products (15)
- Shortages and supply disruptions (13)
- Committees and advisory bodies (9)
- Cosmetics (5)
- Unique Device Identification (UDI) hub (4)
- Clinical trials (3)
- Fees and payments (2)
- Prescription opioids hub (2)
- Urogynaecological (transvaginal) surgical mesh hub (2)
- Breast implant hub (1)
Search
1273 result(s) found, displaying 626 to 650
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Safety updatesMedicines safety update - important information for health professionals
-
Melbourne-based individual fined $5,328 for alleged unlawful importation of nicotine vaping products
Media releasesThe TGA has issued two infringement notices totalling $5,328 to a Melbourne-based individual for alleged unlawful importation of nicotine vaping products. -
Safety updatesMedicines Safety Update - Information for health professionals
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesThe TGA has provisionally approved the Moderna CoVID-19 vaccine, SPIKEVAX, for use in individuals 6 years and older.
-
Media releasesThe TGA has issued an infringement notice of $13,320 to Victorian-based company TCF Trading Co Pty Ltd for alleged unlawful importation of COVID-19 rapid antigen tests.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesJMIT Distributors Pty Ltd fined $79,920 for alleged advertising breaches of nicotine vaping products under the Therapeutic Goods Act 1989
-
Media releasesNSW executive officer fined $10,656 for alleged advertising breaches of the Therapeutic Goods Act 1989 involving nicotine vaping products
-
Media releasesThe TGA has provisionally approved the AstraZeneca COVID-19 vaccine, Vaxzevria, for use as a booster in individuals aged 18 years and over.
-
News articlesThe TGA has granted a second provisional determination to Gilead Sciences Pty Ltd in relation to its COVID-19 treatment, VEKLURY (remdesivir).
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Safety updatesMedicines Safety Update - Information for health professionals
-
Media releasesThe TGA has provisionally approved the Pfizer Australia Pty Ltd COVID-19 vaccine, COMIRNATY, for use as a booster in individuals aged 16 and 17 years old.
-
Media releasesNo special exemptions to import or supply unapproved RATs
-
Regulatory decision noticesLabelling exemption for COVID-19 Vaccine - Novavax.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Regulatory decision noticesThis instrument is the Therapeutic Goods (Poisons Standard) (COVID-19 Treatment—Merck Sharp and Dohme) (Molnupiravir) Labelling Exemption 2022.
-
Regulatory decision noticesThis labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard.
-
COVID-19 vaccine safety reportsTGA's safety monitoring of COVID-19 vaccines.
-
Media releasesThe TGA has granted provisional approval to two oral COVID-19 treatments.
-
Media releasesOn 19 January 2022 the TGA granted provisional approval to Biocelect Pty Ltd (on behalf of Novavax Inc) in relation to the COVID-19 vaccine, NVX-CoV2373, for individuals aged 18 years and over.
-
Safety updatesAcellur Dermal Matrix Products used in Breast Reconstruction - clarification on reports of potential higher complication rates.
-
Safety updatesMedicines Safety Update - Information for health professionals